IRadimed Corporation announced that its Board of Directors approved the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share (approximately $1.9 million). This initial quarterly dividend implies a $0.60 per share per annum rate (approximately $7.6 million per annum).

The quarterly dividend are payable on January 12, 2024, to shareholders of record at the close of business on December 22, 2023.